Advertisement

Lymphedema pp 19-31 | Cite as

Genetic Causes of Lymphedema

  • Matthieu J. Schlögel
  • Pascal Brouillard
  • Laurence M. Boon
  • Miikka VikkulaEmail author

Abstract

For this chapter, an extensive review of the literature regarding the genes and clinical presentations associated with primary lymphedema is performed. All the signs that have been mentioned for the patients with a proven mutation are catalogued. The phenotypes are divided into two groups depending on whether lymphedema is a primary or a secondary key for diagnosis. This should help clinicians to identify more easily the best candidate gene. Yet, because of the high number of associated genes and the large phenotypic variability, a panel approach to screen all genes at once is likely the most efficient approach for diagnosis.

Keywords

Lymphedema Genetic Mutation Gene Sequencing Genotype–phenotype correlation Counseling Pathophysiology Diagnostics Symptoms 

References

  1. 1.
    Balboa-Beltran E, Fernandez-Seara MJ, Perez-Munuzuri A, Lago R, Garcia-Magan C, Couce ML, et al. A novel stop mutation in the vascular endothelial growth factor-C gene (VEGFC) results in Milroy-like disease. J Med Genet. 2014;51(7):475–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Gordon K, Spiden SL, Connell FC, Brice G, Cottrell S, Short J, et al. FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update. Hum Mutat. 2013;34(1):23–31.CrossRefPubMedGoogle Scholar
  3. 3.
    Connell F, Brice G, Jeffery S, Keeley V, Mortimer P, Mansour S. A new classification system for primary lymphatic dysplasias based on phenotype. Clin Genet. 2010;77(5):438–52.CrossRefPubMedGoogle Scholar
  4. 4.
    Finegold DN, Kimak MA, Lawrence EC, Levinson KL, Cherniske EM, Pober BR, et al. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet. 2001;10(11):1185–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Ferrell RE, Baty CJ, Kimak MA, Karlsson JM, Lawrence EC, Franke-Snyder M, et al. GJC2 missense mutations cause human lymphedema. Am J Hum Genet. 2010;86(6):943–8.CrossRefPubMedCentralPubMedGoogle Scholar
  6. 6.
    Brice G, Ostergaard P, Jeffery S, Gordon K, Mortimer PS, Mansour S. A novel mutation in GJA1 causing oculodentodigital syndrome and primary lymphoedema in a three generation family. Clin Genet. 2013;84(4):378–81.CrossRefPubMedGoogle Scholar
  7. 7.
    Alders M, Al-Gazali L, Cordeiro I, Dallapiccola B, Garavelli L, Tuysuz B, et al. Hennekam syndrome can be caused by FAT4 mutations and be allelic to Van Maldergem syndrome. Hum Genet. 2014;133(9):1161–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123(6):809–21.CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Kawai T, Nishikomori R, Heike T. Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency. Allergol Int. 2012;61(2):207–17.CrossRefPubMedGoogle Scholar
  10. 10.
    Au AC, Hernandez PA, Lieber E, Nadroo AM, Shen YM, Kelley KA, et al. Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans. Am J Hum Genet. 2010;87(3):436–44.CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Irrthum A, Devriendt K, Chitayat D, Matthijs G, Glade C, Steijlen PM, et al. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet. 2003;72(6):1470–8.CrossRefPubMedCentralPubMedGoogle Scholar
  12. 12.
    Moalem S, Brouillard P, Kuypers D, Legius E, Harvey E, Taylor G, et al. Hypotrichosis-lymphedema-telangiectasia-renal defect associated with a truncating mutation in the SOX18 gene. Clin Genet. 2014. Article first published online: 16 APR 2014, DOI: 10.1111/cge.12388.Google Scholar
  13. 13.
    Geffrey AL, Shinnick JE, Staley BA, Boronat S, Thiele EA. Lymphedema in tuberous sclerosis complex. Am J Med Genet A. 2014;164A(6):1438–42.CrossRefPubMedGoogle Scholar
  14. 14.
    Rauen KA. The RASopathies. Annu Rev Genomics Hum Genet. 2013;14:355–69.CrossRefPubMedCentralPubMedGoogle Scholar
  15. 15.
    Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, et al. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2010;126(4):746–59.CrossRefPubMedGoogle Scholar
  16. 16.
    Sybert VP, McCauley E. Turner’s syndrome. N Engl J Med. 2004;351(12):1227–38.CrossRefPubMedGoogle Scholar
  17. 17.
    Revencu N, Boon LM, Mendola A, Cordisco MR, Dubois J, Clapuyt P, et al. RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat. 2013;34(12):1632–41.CrossRefPubMedGoogle Scholar
  18. 18.
    Burrows PE, Gonzalez-Garay ML, Rasmussen JC, Aldrich MB, Guilliod R, Maus EA, et al. Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man. Proc Natl Acad Sci U S A. 2013;110(21):8621–6.CrossRefPubMedCentralPubMedGoogle Scholar
  19. 19.
    Mendola A, Schlogel MJ, Ghalamkarpour A, Irrthum A, Nguyen HL, Fastre E, et al. Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema. Mol Syndromol. 2013;4(6):257–66.CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Lepri FR, Scavelli R, Digilio MC, Gnazzo M, Grotta S, Dentici ML, et al. Diagnosis of Noonan syndrome and related disorders using target next generation sequencing. BMC Med Genet. 2014;15:14.CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Brouillard P, Boon L, Vikkula M. Genetics of lymphatic anomalies. J Clin Invest. 2014;124(3):898–904.CrossRefPubMedCentralPubMedGoogle Scholar
  22. 22.
    Ivanov KI, Agalarov Y, Valmu L, Samuilova O, Liebl J, Houhou N, et al. Phosphorylation regulates FOXC2-mediated transcription in lymphatic endothelial cells. Mol Cell Biol. 2013;33(19):3749–61.CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Wu YH, Hu TF, Chen YC, Tsai YN, Tsai YH, Cheng CC, et al. The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility. Blood. 2011;118(10):2896–905.CrossRefPubMedGoogle Scholar
  24. 24.
    Sevick-Muraca EM, King PD. Lymphatic vessel abnormalities arising from disorders of Ras signal transduction. Trends Cardiovasc Med. 2014;24(3):121–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Moncrieff M, Shannon K, Hong A, Hersey P, Thompson J. Dramatic reduction of chronic lymphoedema of the lower limb with sorafenib therapy. Melanoma Res. 2008;18(2):161–2.CrossRefPubMedGoogle Scholar
  26. 26.
    Honkonen KM, Visuri MT, Tervala TV, Halonen PJ, Koivisto M, Lahteenvuo MT, et al. Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema. Ann Surg. 2013;257(5):961–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H, et al. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation. 2006;114(11):1177–84.CrossRefPubMedGoogle Scholar
  28. 28.
    Finegold DN, Baty CJ, Knickelbein KZ, Perschke S, Noon SE, Campbell D, et al. Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res. 2012;18(8):2382–90.CrossRefPubMedCentralPubMedGoogle Scholar
  29. 29.
    Miaskowski C, Dodd M, Paul SM, West C, Hamolsky D, Abrams G, et al. Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery. PLoS One. 2013;8(4):e60164.CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Matthieu J. Schlögel
    • 1
  • Pascal Brouillard
    • 1
  • Laurence M. Boon
    • 2
  • Miikka Vikkula
    • 1
    • 3
    Email author
  1. 1.Laboratory of Human Molecular Genetics, de Duve InstituteUniversité catholique de LouvainBrusselsBelgium
  2. 2.Cliniques universitaires Saint-Luc, Center for Vascular AnomaliesUniversite catholique de LouvainBrusselsBelgium
  3. 3.Walloon Excellence in Lifesciences and Biotechnology (WELBIO)BrusselsBelgium

Personalised recommendations